301 related articles for article (PubMed ID: 17004514)
1. Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement.
Dunlap B; Paice JA
J Support Oncol; 2006 Sep; 4(8):398-9. PubMed ID: 17004514
[No Abstract] [Full Text] [Related]
2. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Amara S
Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.
Wickham R
Clin J Oncol Nurs; 2007 Jun; 11(3):361-76. PubMed ID: 17623621
[TBL] [Abstract][Full Text] [Related]
4. Peripheral neuropathy induced by oxaliplatin-based chemotherapy.
J Support Oncol; 2006 Feb; 4(2):82-3. PubMed ID: 16499128
[No Abstract] [Full Text] [Related]
5. [Drug induced neuropathies].
Lagueny A
Rev Prat; 2008 Nov; 58(17):1910-6. PubMed ID: 19157207
[TBL] [Abstract][Full Text] [Related]
6. [[Peripheral nervous system neurotoxicity secondary to chemotherapy treatment] ].
Iñiguez C; Larrodé P; Mayordomo JI; Mauri JA; Trés A; Morales F
Neurologia; 2000 Oct; 15(8):343-51. PubMed ID: 11143501
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy-induced peripheral neuropathy: Symptomatology and epidemiology].
Kerckhove N; Collin A; Condé S; Chaleteix C; Pezet D; Balayssac D; Guastella V
Bull Cancer; 2018 Nov; 105(11):1020-1032. PubMed ID: 30244980
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin scale and National Cancer Institute-Common Toxicity Criteria in the assessment of chemotherapy-induced peripheral neuropathy.
Kautio AL; Haanpää M; Kautiainen H; Leminen A; Kalso E; Saarto T
Anticancer Res; 2011 Oct; 31(10):3493-6. PubMed ID: 21965767
[TBL] [Abstract][Full Text] [Related]
9. [Peripheral neuropathy as a side effect of chemotherapy and targeted therapy].
Gießen-Jung C; von Baumgarten L
Dtsch Med Wochenschr; 2018 Jul; 113(13):970-978. PubMed ID: 29972842
[TBL] [Abstract][Full Text] [Related]
10. [Neurotoxicity and dermatologic toxicity of cancer chemotherapy].
Nakane M
Gan To Kagaku Ryoho; 2006 Jan; 33(1):29-33. PubMed ID: 16410694
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy-induced peripheral neuropathy].
Noguchi E; Maeda Y
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
[TBL] [Abstract][Full Text] [Related]
12. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced peripheral neuropathy: the end of the beginning?
Krishnan AV; Park SB
J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):359. PubMed ID: 23833264
[No Abstract] [Full Text] [Related]
14. Neuropathic pain and balance problems are poorly evaluated in patients receiving taxane-based chemotherapy.
J Support Oncol; 2005; 3(6):412. PubMed ID: 16350427
[No Abstract] [Full Text] [Related]
15. Liability of the voltage-gated sodium channel gene SCN2A R19K polymorphism to oxaliplatin-induced peripheral neuropathy.
Argyriou AA; Antonacopoulou AG; Scopa CD; Kottorou A; Kominea A; Peroukides S; Kalofonos HP
Oncology; 2009; 77(3-4):254-6. PubMed ID: 19738391
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy.
Argyriou AA; Chroni E; Polychronopoulos P; Iconomou G; Koutras A; Makatsoris T; Gerolymos MK; Gourzis P; Assimakopoulos K; Kalofonos HP
Neurology; 2006 Dec; 67(12):2253-5. PubMed ID: 17190958
[TBL] [Abstract][Full Text] [Related]
17. Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview.
Chan A; Hertz DL; Morales M; Adams EJ; Gordon S; Tan CJ; Staff NP; Kamath J; Oh J; Shinde S; Pon D; Dixit N; D'Olimpio J; Dumitrescu C; Gobbo M; Kober K; Mayo S; Pang L; Subbiah I; Beutler AS; Peters KB; Loprinzi C; Lustberg MB
Support Care Cancer; 2019 Oct; 27(10):3729-3737. PubMed ID: 31363906
[TBL] [Abstract][Full Text] [Related]
18. Exploration of platinum-induced neuropathy should be based on both objective and subjective examinations.
Oldenburg J; Fosså SD
Acta Oncol; 2009; 48(6):804-6. PubMed ID: 19484592
[No Abstract] [Full Text] [Related]
19. Oxaliplatin induced-neuropathy in digestive tumors.
Sereno M; Gutiérrez-Gutiérrez G; Gómez-Raposo C; López-Gómez M; Merino-Salvador M; Tébar FZ; Rodriguez-Antona C; Casado E
Crit Rev Oncol Hematol; 2014 Jan; 89(1):166-78. PubMed ID: 24029604
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.
Hausheer FH; Schilsky RL; Bain S; Berghorn EJ; Lieberman F
Semin Oncol; 2006 Feb; 33(1):15-49. PubMed ID: 16473643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
